HeartCycle

HeartCycle consortium, comprising 18 research, academic, industrial and medical organizations from 9 different European countries and China, will work to improve the quality of life for coronary heart disease and heart failure patients by monitoring their condition and involving them in the daily management of their disease. The consortium will also develop mechanisms to automatically report relevant monitoring data back to clinicians so that they can prescribe personalized therapies and lifestyle recommendations.

Compliance to prescribed therapies is a common problem associated with long-term treatment, and will become even more problematic as the European population ages and chronic disease becomes more prevalent. There is strong evidence that increasing the level of patient compliance may have a far greater impact on the health of the population than improvements in specific medical treatments. The HeartCycle project intends to tackle this in two ways.

Firstly by creating a 'patient loop' that gives patients continuous feedback on their state of health, their progress towards achieving health status milestones, plus motivational tips and suggestions for a healthy lifestyle and diet. In the course of the project it will be investigated whether such measures will improve the adherence to prescribed therapies. Monitoring each patient's condition will be achieved using a combination of unobtrusive bio-sensors built into the patient's clothing or bed sheets and home appliances such as weighing scales and blood pressure monitors. Sensing of an individual patient's physical exertion, body orientation and ambient environment will provide additional information so that the system can put the monitoring data into context.

Secondly by enabling a 'professional loop' in which relevant data on a patient’s state of health and therapy adherence is automatically communicated to a hospital information system. This professional loop will allow doctors to monitor each patient's condition and therapy response in order to create optimized individual care plans, as well as allowing them to identify deterioration or sudden cardiac events that require immediate remedial action.

For further information, please visit:
http://www.heartcycle.eu

Project co-ordinator:
Philips Research

Partners:

  • Aristotle University of Thessaloniki (Greece);
  • Clothing Plus Oy (Finland);
  • CSEM Centre Suisse D'electronique Et De Microtechnique Sa (Switzerland);
  • Empirica Gesellschaft für Kommunikations und Technologieforschung mbH (Germany);
  • Faculdade Ciencias e Tecnologia da Universidade de Coimbra (Portugal);
  • Fundación Vodafone España (Spain);
  • Hospital Universitario Clínico San Carlos (Spain);
  • Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas (Spain);
  • Medtronic Ibérica SA (Spain);
  • Philips Electronics Nederland B.V. (The Netherlands);
  • Philips Research (Germany);
  • Politecnico Di Milano - Dipartimento di Bioingegneria (Italy);
  • Rheinisch Westfälische Technische Hochschule (Germany);
  • T-Systems ITC Iberia SA (Spain);
  • Universidad Politécnica de Madrid (Spain);
  • Chinese University of Hong Kong (China);
  • University of Hull (United Kingdom);
  • Valtion Teknillinen Tutkimuskeskus (Finland).

Timetable: from 03/2008 – to 02/2012

Total cost: € 21.985.444

EC funding: € 14.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Personal health systems for monitoring and point-of-care diagnostics

Contract type: Collaborative project (generic)


Related news articles:

Most Popular Now

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...

AI could Crack the Language of Cancer an…

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

X-Rays Combined with AI Offer Fast Diagn…

X-rays, first used clinically in the late 1890s, could be a leading-edge diagnostic tool for COVID-19 patients with the help of artificial intelligence, according to a team of researchers in...

Predicting COVID-19 Outbreaks with Cell …

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal).